መነሻPTKFY • OTCMKTS
add
PT Kalbe Farma Unsponsored Indonesia ADR
የቀዳሚ መዝጊያ
$19.94
የዓመት ክልል
$16.38 - $23.73
የገበያው አጠቃላይ ዋጋ
68.91 ት IDR
አማካይ መጠን
1.13 ሺ
የገበያ ዜና
.INX
0.35%
3.22%
ፋይናንስ
የገቢ መግለጫ
ገቢ
የተጣራ ገቢ
(IDR) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ገቢ | 7.91 ት | 7.16% |
የሥራ ወጪ | 2.29 ት | 15.55% |
የተጣራ ገቢ | 573.28 ቢ | 6.97% |
የተጣራ የትርፍ ክልል | 7.25 | -0.14% |
ገቢ በሼር | 12.41 | 7.73% |
EBITDA | 874.81 ቢ | 1.14% |
ውጤታማ የግብር ተመን | 23.01% | — |
ቀሪ ሒሳብ ሉሆች
አጠቃላይ ንብረቶች
አጠቃላይ ተጠያቂነቶች
(IDR) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ጥሬ ገንዘብና የአጭር ጊዜ መዋዕለ ንዋይ | 4.32 ት | 45.45% |
አጠቃላይ ንብረቶች | 28.75 ት | 5.78% |
አጠቃላይ ተጠያቂነቶች | 4.84 ት | 0.67% |
አጠቃላይ እሴት | 23.91 ት | — |
የሼሮቹ ብዛት | 46.15 ቢ | — |
የገበያ ዋጋ እና የተገለጸ ዋጋ | 0.04 | — |
የእሴቶች ተመላሽ | 6.15% | — |
የካፒታል ተመላሽ | 7.16% | — |
የገንዘብ ፍሰት
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ
(IDR) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
የተጣራ ገቢ | 573.28 ቢ | 6.97% |
ከክወናዎች የተገኘ ጥሬ ገንዘብ | 1.16 ት | 22.56% |
ገንዘብ ከኢንቨስትመንት | -176.64 ቢ | 33.78% |
ገንዘብ ከፋይናንስ | -421.11 ቢ | 51.91% |
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ | 481.86 ቢ | 1,978.42% |
ነፃ የገንዘብ ፍሰት | 752.00 ቢ | 13.84% |
ስለ
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, distribution arm that reaches over 1 million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. Wikipedia
የተመሰረተው
10 ሴፕቴ 1966
ድህረገፅ
ሠራተኞች
12,924